Di-cyclopropyl based IL-17A modulators and uses thereof

The disclosure herein provides compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) for the modulation of IL-17A. Compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) are useful for the treatment of inflammatory conditions, such as psoriasis.

Saved in:
Bibliographic Details
Main Authors FATHEREE, PAUL R, PAULICK, MARGOT G, CHURCH, TIMOTHY J, REILLY, MAUREEN, LINSELL, MARTIN S
Format Patent
LanguageChinese
English
Published 01.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure herein provides compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) for the modulation of IL-17A. Compounds and pharmaceutical compositions of Formula (I) and Formula (I-A) are useful for the treatment of inflammatory conditions, such as psoriasis.
Bibliography:Application Number: TW20230106593